NFKB1 and lung adenocarcinoma: Indeed, tailored bortezomib treatment suppressed NF-κB-dependent gene expression of lung adenocarcinoma in vitro and in vivo, resulting in down-regulation of all major paracrine phenomena known to be involved in MPE formation: inflammation, vascular hyperpermeability, and neoangiogenesis.